Remifentanil Protects against Lipopolysaccharide-Induced Inflammation through PARP-1/NF-κB Signaling Pathway

Remifentanil Protects against Lipopolysaccharide-Induced Inflammation through PARP-1/NF-κB Signaling Pathway

Sepsis is a leading cause of death in patients with severe infection worldwide. Remifentanil is an ultra-short-acting, potent opioid analgesic. In the study, we aimed to investigate the role and underlying mechanism of remifentanil in lipopolysaccharide- (LPS-) induced inflammation in human aortic e...

Full description

Saved in:
Bibliographic Details
Main Authors: Jian-ning Zhang (Author), Yang Ma (Author), Xi-yan Wei (Author), Ke-yin Liu (Author), Hao Wang (Author), Hui Han (Author), Yi Cui (Author), Ming-xiang Zhang (Author), Wei-dong Qin (Author)
Format: Book
Published: Hindawi Limited, 2019-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items